Английская Википедия:Addiction-related structural neuroplasticity

Материал из Онлайн справочника
Версия от 05:11, 1 января 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|None}} {{more medical citations needed|date=June 2015}} Addiction is a state characterized by compulsive engagement in rewarding stimuli, despite adverse consequences. The process of developing an addiction occurs through instrumental learning, which is otherwise known as operant conditioning. Neuroscientists believe that dr...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:More medical citations needed

Addiction is a state characterized by compulsive engagement in rewarding stimuli, despite adverse consequences. The process of developing an addiction occurs through instrumental learning, which is otherwise known as operant conditioning.

Neuroscientists believe that drug addicts’ behavior is a direct correlation to some physiological change in their brain, caused by using drugs. This view believes there is a bodily function in the brain causing the addiction. This is brought on by a change in the brain caused by brain damage or adaptation from chronic drug use.[1][2]

In humans, addiction is diagnosed according to diagnostic models such as the Diagnostic and Statistical Manual of Mental Disorders, through observed behaviors. There has been significant advancement in understanding the structural changes that occur in parts of the brain involved in the reward pathway (mesolimbic system) that underlies addiction.[3] Most research has focused on two portions of the brain: the ventral tegmental area, (VTA) and the nucleus accumbens (NAc).[4]

The VTA is the portion of the mesolimbic system responsible for spreading dopamine to the whole system. The VTA is stimulated by ″rewarding experiences″. The release of dopamine by the VTA induces pleasure, thus reinforcing behaviors that lead to the reward.[5] Drugs of abuse increase the VTA's ability to project dopamine to the rest of the reward circuit.[6] These structural changes only last 7–10 days,[7] however, indicating that the VTA cannot be the only part of the brain that is affected by drug use, and changed during the development of addiction.

The nucleus accumbens (NAc) plays an essential part in the formation of addiction. Almost every drug with addictive potential induces the release of dopamine into the NAc.[8] In contrast to the VTA, the NAc shows long-term structural changes. Drugs of abuse weaken the connections within the NAc after habitual use,[9] as well as after use then withdrawal.[10]

Structural changes of learning

Learning by experience occurs through modifications of the structural circuits of the brain. These circuits are composed of many neurons and their connections, called synapses, which occur between the axon of one neuron and the dendrite of another. A single neuron generally has many dendrites which are called dendritic branches, each of which can be synapsed by many axons.

Along dendritic branches there can be hundreds or even thousands of dendritic spines, structural protrusions that are sites of excitatory synapses. These spines increase the number of axons from which the dendrite can receive information. Dendritic spines are very plastic, meaning they can be formed and eliminated very quickly, in the order of a few hours.Шаблон:Citation needed More spines grow on a dendrite when it is repetitively activated. Dendritic spine changes have been correlated with long-term potentiation (LTP) and long-term depression (LTD).[11][12]

LTP is the way that connections between neurons and synapses are strengthened. LTD is the process by which synapses are weakened. For LTP to occur, NMDA receptors on the dendritic spine send intracellular signals to increase the number of AMPA receptors on the post synaptic neuron. If a spine is stabilized by repeated activation, the spine becomes mushroom shaped and acquires many more AMPA receptors. This structural change, which is the basis of LTP, persists for months and may be an explanation for some of the long-term behavioral changes that are associated with learned behaviors including addiction to drugs.[13]

Research methodologies

Animal models

Animal models, especially rats and mice, are used for many types of biological research. The animal models of addiction are particularly useful because animals that are addicted to a substance show behaviors similar to human addicts. This implies that the structural changes that can be observed after the animal ingests a drug can be correlated with an animal's behavioral changes, as well as with similar changes occurring in humans.

Administration protocols

Administration of drugs that are often abused can be done either by the experimenter (non-contingent), or by a self-administration (contingent) method. The latter usually involves the animal pressing a lever to receive a drug. Non-contingent models are generally used for convenience, being useful for examining the pharmacological and structural effects of the drugs. Contingent methods are more realistic because the animal controls when and how much of the drug it receives. This is generally considered a better method for studying the behaviors associated with addiction. Contingent administration of drugs has been shown to produce larger structural changes in certain parts of the brain, in comparison to non-contingent administration.[14]

Types of drugs

All abused drugs directly or indirectly promote dopamine signaling in the mesolimbic dopamine neurons which project from the ventral tegmental area to the nucleus accumbens (NAc).[8] The types of drugs used in experimentation increase this dopamine release through different mechanisms.

Opiates

Opiates are a class of sedative with the capacity for pain relief. Morphine is an opiate that is commonly used in animal testing of addiction. Opiates stimulate dopamine neurons in the brain indirectly by inhibiting GABA release from modulatory interneurons that synapse onto the dopamine neurons. GABA is an inhibitory neurotransmitter that decreases the probability that the target neuron will send a subsequent signal.

Stimulants

Stimulants used regularly in neuroscience experimentation are cocaine and amphetamine. These drugs induce an increase in synaptic dopamine by inhibiting the reuptake of dopamine from the synaptic cleft, effectively increasing the amount of dopamine that reaches the target neuron. Шаблон:FOSB addiction table

The reward pathway

The reward pathway, also called the mesolimbic system of the brain, is the part of the brain that registers reward and pleasure. This circuit reinforces the behavior that leads to a positive and pleasurable outcome. In drug addiction, the drug-seeking behaviors become reinforced by the rush of dopamine that follows the administration of a drug of abuse. The effects of drugs of abuse on the ventral tegmental area (VTA) and the nucleus accumbens (NAc) have been studied extensively.[15]

Drugs of abuse change the complexity of dendritic branching as well as the number and size of the branches in both the VTA and the NAc.[16] [7] By correlation, these structural changes have been linked to addictive behaviors. The effect of these structural changes on behavior is uncertain and studies have produced conflicting results. Two studies[17][18] have shown that an increase in dendritic spine density due to cocaine exposure facilitates behavioral sensitization, while two other studies[19][20] produce contradicting evidence.

In response to drugs of abuse, structural changes can be observed in the size of neurons[21] and the shape and number of the synapses between them.[22] The nature of the structural changes is specific to the type of drug used in the experiment. Opiates and stimulants produce opposite effects in structural plasticity in the reward pathway. It is not expected that these drugs would induce opposing structural changes in the brain because these two classes of drugs, opiates and stimulants, both cause similar behavioral phenotypes.

Both of these drugs induce increased locomotor activity acutely, escalated self-administration chronically, and dysphoria when the drug is taken away.Шаблон:Citation needed Although their effects on structural plasticity are opposite, there are two possible explanations as to why these drugs still produce the same indicators of addiction: Either these changes produce the same behavioral phenotype when any change from baseline is produced, or the critical changes that cause the addictive behavior cannot be quantified by measuring dendritic spine density.Шаблон:Citation needed

Opiates decrease spine density and dendrite complexity in the nucleus accumbens (NAc).Шаблон:Citation needed Morphine decreases spine density regardless of the treatment paradigm.Шаблон:Citation needed Either chronic or intermittent administration of morphine will produce the same effect.[14] The only case where opiates increase dendritic density is with chronic morphine exposure, which increases spine density on pyramidal neurons in the orbitofrontal cortex.[23] Stimulants increase spinal density and dendritic complexity in the nucleus accumbens (NAc),[20][22][24][25] ventral tegmental area (VTA),[26] and other structures in the reward circuit.[22][24][25]

Ventral tegmental area

Шаблон:Main article There are neurons with cell bodies in the VTA that release dopamine onto specific parts of the brain, including many of the limbic regions such as the NAc, the medial prefrontal cortex (mPFC), dorsal striatum, amygdala, and the hippocampus. The VTA has both dopaminergic and GABAergic neurons that both project to the NAc and mPFC.[27][28] GABAergic neurons in the VTA also synapse on local dopamine cells.[29] In non-drug models, the VTA dopamine neurons are stimulated by rewarding experiences.[5] A release of dopamine from the VTA neurons seems to be the driving action behind drug-induced pleasure and reward.

Exposure to drugs of abuse elicits LTP at excitatory synapses on VTA dopamine neurons.[6] Excitatory synapses in brain slices from the VTA taken 24 hours after a single cocaine exposure showed an increase in AMPA receptors in comparison to a saline control.[30] Additional LTP could not be induced in these synapses. This is thought to be because the maximal amount of LTP had already been induced by the administration of cocaine.Шаблон:Citation needed LTP is only seen on the dopamine neurons, not on neighboring GABAergic neurons. This is of interest because the administration of drugs of abuse increases the excitation of VTA dopamine neurons, but does not increase inhibition.Шаблон:Citation needed Excitatory inputs into the VTA will activate the dopamine neurons 200%, but do not increase activation of GABA neurons which are important in local inhibition.[31]

This effect of inducing LTP in VTA slices 24 hours after drug exposure has been shown using morphine, nicotine, ethanol, cocaine, and amphetamines. These drugs have very little in common except that they are all potentially addictive. This is evidence supporting a link between structural changes in the VTA and the development of addiction.Шаблон:Citation needed

Changes other than LTP have been observed in the VTA after treatment with drugs of abuse. For example, neuronal body size decreased in response to opiates.[8][14][21][32]

Although the structural changes in the VTA invoked by exposure to an addictive drug generally disappear after a week or two, the target regions of the VTA, including the NAc, may be where the longer-term changes associated with addiction occur during the development of the addiction.[7][33][34]

Nucleus accumbens

Шаблон:Main article The nucleus accumbens plays an integral role in addiction. Almost every addictive drug of abuse induces the release of dopamine into the nucleus accumbens.[8][35][36] The NAc is particularly important for instrumental learning, including cue-induced reinstatement of drug-seeking behavior.[37] It is also involved in mediating the initial reinforcing effects of addictive drugs.[38][39] The most common cell type in the NAc is the GABAergic medium spiny neuron.[40] These neurons project inhibitory connections to the VTA and receive excitatory input from various other structures in the limbic system. Changes in the excitatory synaptic inputs into these neurons have been shown to be important in mediating addiction-related behaviors.[41] It has been shown that LTP and LTD occurs at NAc excitatory synapses.[42]

Unlike the VTA, a single dose of cocaine induces no change in potentiation in the excitatory synapses of the NAc.[43] LTD was observed in the medium spiny neurons in the NAc following two different protocols: a daily cocaine administration for five days[9] or a single dose followed by 10–14 days of withdrawal.[10] This suggests that the structural changes in the NAc are associated with long-term behaviors (rather than acute responses) associated with addiction such as drug seeking.[44]

Human relevance

Relapse

Neuroscientists studying addiction define relapse as the reinstatement of drug-seeking behavior after a period of abstinence. The structural changes in the VTA are hypothesized to contribute to relapse.[45] Once the molecular mechanisms of relapse are better understood, a pharmacological treatment may be developed to prevent it.Шаблон:Speculation inline

Relapse is the biggest problem for recovering addictsШаблон:Speculation inline; an addict can be forced to abstain from using drugs while they are admitted in a treatment clinic, but once they leave the clinic they are at risk of relapse. Relapse can be triggered by stress, cues associated with past drug use, or re-exposure to the substance. Animal models of relapse can be triggered in the same way.[45]

Search for a cure for addiction

The goal of addiction research is to find ways to prevent and reverse the effects of addiction on the brain. Theoretically, if the structural changes in the brain associated with addiction can be blocked, then the negative behaviors associated with the disease should never develop.

Structural changes associated with addiction can be inhibited by NMDA receptor antagonists which block the activity of NMDA receptors.[45] NMDA receptors are essential in the process of LTP and LTD.[30] Drugs of this class are unlikely candidates for pharmacological prevention of addiction because these drugs themselves are used recreationally. Examples of NMDAR antagonists are ketamine, dextromethorphan (DXM), phencyclidine (PCP).

References

Шаблон:Reflist

  1. Шаблон:Cite journal
  2. Шаблон:Cite journal
  3. Шаблон:Cite journal
  4. Шаблон:Cite journal
  5. 5,0 5,1 Ошибка цитирования Неверный тег <ref>; для сносок Schultz 1997 не указан текст
  6. 6,0 6,1 Ошибка цитирования Неверный тег <ref>; для сносок Ungless 2001 не указан текст
  7. 7,0 7,1 Ошибка цитирования Неверный тег <ref>; для сносок Nestler 2001 не указан текст
  8. 8,0 8,1 8,2 8,3 Ошибка цитирования Неверный тег <ref>; для сносок Nestler 1992 не указан текст
  9. 9,0 9,1 Ошибка цитирования Неверный тег <ref>; для сносок Kourrich 2007 не указан текст
  10. 10,0 10,1 Ошибка цитирования Неверный тег <ref>; для сносок Thomas 2001 не указан текст
  11. Ошибка цитирования Неверный тег <ref>; для сносок Bourne 2007 не указан текст
  12. Ошибка цитирования Неверный тег <ref>; для сносок Carlisle 2005 не указан текст
  13. Шаблон:Cite journal
  14. 14,0 14,1 14,2 Ошибка цитирования Неверный тег <ref>; для сносок Robinson 2004 не указан текст
  15. Шаблон:Cite journal
  16. Ошибка цитирования Неверный тег <ref>; для сносок Russo 2010 не указан текст
  17. Ошибка цитирования Неверный тег <ref>; для сносок Pulipparacharuvil 2008 не указан текст
  18. Ошибка цитирования Неверный тег <ref>; для сносок Russo 2009 не указан текст
  19. Ошибка цитирования Неверный тег <ref>; для сносок Maze 2010 не указан текст
  20. 20,0 20,1 Ошибка цитирования Неверный тег <ref>; для сносок Norrholm 2003 не указан текст
  21. 21,0 21,1 Ошибка цитирования Неверный тег <ref>; для сносок Sklair 1996 не указан текст
  22. 22,0 22,1 22,2 Ошибка цитирования Неверный тег <ref>; для сносок Robinson 1997 не указан текст
  23. Ошибка цитирования Неверный тег <ref>; для сносок Robinson 2002 не указан текст
  24. 24,0 24,1 Ошибка цитирования Неверный тег <ref>; для сносок Robinson 2001 не указан текст
  25. 25,0 25,1 Ошибка цитирования Неверный тег <ref>; для сносок Robinson 1999 не указан текст
  26. Ошибка цитирования Неверный тег <ref>; для сносок Sarti 2007 не указан текст
  27. Ошибка цитирования Неверный тег <ref>; для сносок Grace 1989 не указан текст
  28. Ошибка цитирования Неверный тег <ref>; для сносок Johnson 1992 не указан текст
  29. Ошибка цитирования Неверный тег <ref>; для сносок Johnson 1992 JNeuro не указан текст
  30. 30,0 30,1 Ошибка цитирования Неверный тег <ref>; для сносок Malinow 2002 не указан текст
  31. Ошибка цитирования Неверный тег <ref>; для сносок Cameron 1993 не указан текст
  32. Ошибка цитирования Неверный тег <ref>; для сносок Russo 2007 не указан текст
  33. Ошибка цитирования Неверный тег <ref>; для сносок Gerdeman 2003 не указан текст
  34. Ошибка цитирования Неверный тег <ref>; для сносок Nestler 2002 не указан текст
  35. Ошибка цитирования Неверный тег <ref>; для сносок Di Chiara 1988 не указан текст
  36. Ошибка цитирования Неверный тег <ref>; для сносок Koob 1992 не указан текст
  37. Ошибка цитирования Неверный тег <ref>; для сносок Cardinal 2004 не указан текст
  38. Ошибка цитирования Неверный тег <ref>; для сносок Kalivas 2005 не указан текст
  39. Ошибка цитирования Неверный тег <ref>; для сносок Pierce 2006 не указан текст
  40. Ошибка цитирования Неверный тег <ref>; для сносок Sesack 2010 не указан текст
  41. Ошибка цитирования Неверный тег <ref>; для сносок Hyman 2001 не указан текст
  42. Ошибка цитирования Неверный тег <ref>; для сносок Yao 2004 не указан текст
  43. Ошибка цитирования Неверный тег <ref>; для сносок Luscher 2011 не указан текст
  44. Ошибка цитирования Неверный тег <ref>; для сносок Kauer 2007 не указан текст
  45. 45,0 45,1 45,2 Ошибка цитирования Неверный тег <ref>; для сносок Kauer 2004 не указан текст